Ionis Pharmaceuticals reported $-95.22M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Agios Pharmaceuticals USD -109.2M 540K Jun/2026
Alnylam Pharmaceuticals USD 360.27M 114.93M Sep/2026
Arrowhead Research USD -212.62M 64.94M Sep/2026
Astellas Pharma JPY 182.02B 53.22B Sep/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
BioMarin Pharmaceutical USD 54.32M 167.99M Sep/2026
Celltrion KRW 25.72B 6.08B Jun/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Divis Laboratories Ltd INR 15.66B 3.04B Sep/2026
Exelixis USD 275.36M 19.96M Sep/2026
Halozyme Therapeutics USD 336.16M 7.34M Sep/2026
Ionis Pharmaceuticals USD -95.22M 9.99M Sep/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Moderna USD -687M 571M Jun/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Neurocrine Biosciences USD 375.3M 185.4M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Omeros USD -47.96M 7.39M Sep/2023
OPKO Health USD 20.39M 48.2M Jun/2026
Organigram Holdings CAD 15.45M 20.21M Jun/2026
Pfizer USD 6.36B 350M Sep/2026
Pharma Mar EUR 9.63M 8.93M Sep/2026
PTC Therapeutics USD 161.9M 99.92M Jun/2026
Qiagen NV USD 219.78M 12.13M Sep/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sarepta Therapeutics USD -3.14M 33.31M Sep/2026
Sartorius EUR 279.9M 600K Sep/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Ultragenyx Pharmaceutical USD -61M 94M Jun/2026
Vertex Pharmaceuticals USD 888.6M 436.6M Sep/2026
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M Jun/2026